Future aspects of modern Parkinson therapy
Ransmayr, G.; Jeschow, M.
Wiener Medizinische Wochenschrift 145(13): 299-301
1995
ISSN/ISBN: 0043-5341 PMID: 7571655 Document Number: 450331
The present limitations of modern antiparkinsonian therapy (decreasing efficacy and increase of side-effects with advancing age and disease duration, lack of causal and neuroprotective therapies) require a multidisciplinary approach in basic, preclinical and clinical research. New substances with higher therapeutic potency and less side-effects, progress in functional stereotaxy, rehabilitation and restorative neurology, and new concepts in neurotransplantation as well as improved knowledge of etiology and pathophysiology are needed for an improvement of therapy.